Merck & Co., Inc. Profit Margin

Data as of June 01, 2026

How It's Calculated

What This Means

Merck & Co., Inc.'s profit margin of 13.6% is solid for many industries, though norms vary widely in Healthcare.

About Merck & Co., Inc.

Merck & Co., Inc. (MRK) operates in the Healthcare sector, specifically in Drug Manufacturers - General. With a market capitalization of about $293.22B, it ranks as a mega-cap stock — one of the largest publicly traded companies.

Shares recently traded near $118.72, within a 52-week range of $75.40 to $125.14 (-5.1% from the high, +57.5% from the low). Beta of 0.20 indicates relatively lower volatility versus the market.

Trailing profit margin is about 13.6%, signaling a solid profit margin for its industry.

Understanding This Metric

Profit margin connects income-statement quality to valuation. For Merck & Co., Inc., trailing margin summarizes how much revenue converts to net profit after costs. In Healthcare, margins differ by business model — software and services often run higher margins than capital-intensive industries. Track margin trends across quarters; a stable or improving margin can support earnings durability, while sharp declines may warrant deeper review of guidance and competition.

Using This Number in Practice

At about 13.6% trailing profit margin, Merck & Co., Inc. (MRK) is in a range often seen among mature operators in its industry. For large revenue bases, even a one-point margin move can shift earnings materially, so trend matters as much as the spot reading.

When comparing MRK to alternatives, combine margin with return on equity, revenue growth, and valuation. Use our margin calculator for scenario work, and browse the MRK metrics hub plus sector peers in the comparison section above.

Sector Comparison

Among Healthcare names on our S&P 100 coverage, Merck & Co., Inc.'s profit margin of 13.6% can be compared with peers such as LLY (35.0%), JNJ (21.8%), UNH (2.7%). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Healthcare stocks.

Key Takeaways

• MRK is grouped in the Healthcare sector for peer comparisons.
• Recent beta of 0.20 suggests lower-than-market price sensitivity.
• Trailing profit margin of 13.6% provides context for how much earnings support the headline multiple.

Related Tools & Guides

Explore calculators and guides connected to this metric, or view all metrics for MRK.

Other MRK Metrics

Frequently Asked Questions